Primary Site >> Liver Cancer

Gene >> TAGLN2

Journal: Br J Cancer. 2005 Mar 14;92(5):929-34.
Title: Identification and analysis of tumour-associated antigens in hepatocellular carcinoma.
Author: Shi, Y-Y|Wang, H-C|Yin, Y-H|Sun, W-S|Li, Y|Zhang, C-Q|Wang, Y|Wang, S|Chen, W-F
PMID: 15756260
Journal: FEBS Lett. 2006 Jun 26;580(15):3571-81.
Title: Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
Author: Huang, Jian|Sheng, Hai-Hui|Shen, Ting|Hu, Yuan-Jie|Xiao, Hua-Sheng|Zhang, Qin|Zhang, Qing-Hua|Han, Ze-Guang
PMID: 16750200
Journal: Oncogene. 2011 Nov 3;30(44):4464-75.
Title: A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.
Author: Leung, W K C|Ching, A K K|Chan, A W H|Poon, T C W|Mian, H|Wong, A S T|To, K-F|Wong, N
PMID: 21577206
Journal: Biochem Biophys Res Commun. 2016 Sep 2;477(4):1051-1058.
Title: TAGLN2, a novel regulator involved in Hepatitis B virus transcription and replication.
Author: Yu, Youjia|He, Zhiliang|Cao, Yong|Tang, Hong|Huang, Feijun
PMID: 27402267